Taken together, these results underscore that selectively augmenting 5-HT production by TPH2 exclusively in eWAT suppresses BAT thermogenesis and EE, while inducing hepatic steatosis and iWAT lipogenesis, leading to the onset of metabolic abnormalities independent of excess caloric intake. Here, TPH2 is linked to fatty liver disease.